Scenarios that move DYN

Dyne Therapeutics, Inc. - Common Stock

Scenarios that move DYN: 1 analysis, 0 positive, 1 negative.

  1. · Satellos wins FDA IND clearance for Forazapadin in FSHD — ▼ · impact -12 · confidence low · horizon quarters

All scenarios · Run a scenario · Pricing